Neuroone Medical Technologies is trading at $2.99 (+8.57%) in pre-market as the stock rebounds from a sharp selloff in the prior session.
- No company-specific catalysts or earnings releases were identified to account for the move.
- The advance appears to be a stock-specific bounce rather than a market-wide trend, given the mixed pre-market tape.
- The name has recently exhibited volatility within the $2.95-$3.21 range following weakness on July 9.